Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Surface Loops Of Trypsin-like Serine Proteases As Determinants Of Function.
P. Goettig, H. Brandstetter, V. Magdolen
Published 2019 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Trypsin and chymotrypsin-like serine proteases from family S1 (clan PA) constitute the largest protease group in humans and more generally in vertebrates. The prototypes chymotrypsin, trypsin and elastase represent simple digestive proteases in the gut, where they cleave nearly any protein. Multidomain trypsin-like proteases are key players in the tightly controlled blood coagulation and complement systems, as well as related proteases that are secreted from diverse immune cells. Some serine proteases are expressed in nearly all tissues and fluids of the human body, such as the human kallikreins and kallikrein-related peptidases with specialization for often unique substrates and accurate timing of activity. HtrA and membrane-anchored serine protease fulfill important physiological tasks with emerging roles in cancer. The high diversity of all family members, which share the tandem β-barrel architecture of the chymotrypsin-fold in the catalytic domain, is conferred by the large differences of eight surface loops, surrounding the active site. The length of these loops alters with insertions and deletions, resulting in remarkably different three-dimensional arrangements. In addition, metal binding sites for Na+, Ca2+ and Zn2+ serve as regulatory elements, as do N-glycosylation sites. Depending on the individual tasks of the protease, the surface loops determine substrate specificity, control the turnover and allow regulation of activation, activity and degradation by other proteins, which are often serine proteases themselves. Most intriguingly, in some serine proteases, the surface loops interact as allosteric network, partially tuned by protein co-factors. Knowledge of these subtle and complicated molecular motions may allow nowadays for new and specific pharmaceutical or medical approaches.
This paper references
Reconstitution of human azurocidin catalytic triad and proteolytic activity by site-directed mutagenesis
M. Olczak (2008)
Granzyme H of Cytotoxic Lymphocytes Is Required for Clearance of the Hepatitis B Virus through Cleavage of the Hepatitis B Virus X Protein
Haidong Tang (2012)
Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences*
M. Debela (2006)
Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2.
M. Kishibe (2012)
Tryptase as a polyfunctional component of mast cells
D. Atiakshin (2018)
An update on factor XI structure and function.
B. Mohammed (2018)
Molecular Determinants of the Mechanism Underlying Acceleration of the Interaction between Antithrombin and Factor Xa by Heparin Pentasaccharide*
N. Quinsey (2002)
Crystallographic and kinetic evidence of allostery in a trypsin-like protease.
Weiling Niu (2011)
Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
M. Debela (2016)
A mental retardation gene, motopsin /neurotrypsin /prss12, modulates hippocampal function and social interaction
S. Mitsui (2009)
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy.
I. Cohen (2016)
Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor‐1 (HAI‐1)
C. Eigenbrot (2010)
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding.
K. Hopfner (1999)
The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex
M. Budayova-Spano (2002)
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
A. J. Ramsay (2009)
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family
O. J. Kyrieleis (2007)
The X-ray crystal structure of full-length human plasminogen.
R. Law (2012)
Coagulation factor XII protease domain crystal structure
M. Pathak (2015)
Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
I. Fernández (2008)
Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate
T. Nakamura (2003)
Asp-70-->Lys mutant of factor X lacks high affinity Ca2+ binding site yet retains function.
A. Rezaie (1994)
Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor
Lars C. Petersen (2000)
Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases.
Q. Dang (1996)
Chapter 584 – Pancreatic Elastases
E. B. Oliveira (2013)
Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase*
R. Friedrich (2002)
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
D. Whitcomb (1996)
Factor B structure provides insights into activation of the central protease of the complement system
F. Milder (2007)
Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans.
Claudio Gisler (2013)
Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex
P. Fuentes-Prior (2000)
Chymotrypsinogen: 2,5-Å crystal structure, comparison with α-chymotrypsin, and implications for zymogen activation
S. Freer (1970)
Thrombin: A paradigm for enzymes allosterically activated by monovalent cations
E. Cera (2004)
Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.
B. C. Lechtenberg (2013)
Introduction: Serine Peptidases and Their Clans
N. Rawlings (2013)
Tissue factor/factor VIIa complex: role of the membrane surface.
J. Morrissey (2012)
Blarina toxin, a mammalian lethal venom from the short-tailed shrew Blarina brevicauda: Isolation and characterization.
Masaki Kita (2004)
Regulation of the protein C anticoagulant and antiinflammatory pathways.
A. Rezaie (2010)
A tick protein with a modified Kunitz fold inhibits human tryptase.
G. Paesen (2007)
Structural basis of profactor D activation: from a highly flexible zymogen to a novel self‐inhibited serine protease, complement factor D
H. Jing (1999)
Chapter 653 – Polyserases
A. Moncada-Pazos (2013)
The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin
Gurdeep Chahal (2015)
An effect of calcium ions on the activity, heat stability, and structure of trypsin.
T. Sipos (1970)
Chapter 630 – Complement Factor D
F. Forneris (2013)
The molecular evolution of genes and proteins: a tale of two serines
S. Brenner (1988)
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.
T. Kryza (2016)
The synthesis and chelation chemistry of DOTA-peptide conjugates.
Luis M De León-Rodríguez (2008)
The structure of bovine trypsin : Electron density maps of the inhibited enzyme at 5 Å and at 2·7 Å resolution☆
R. Stroud (1974)
Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases
P. Goettig (2016)
Molecular motion regulates the activity of the Mitochondrial Serine Protease HtrA2
M. Merski (2017)
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
B. Korkmaz (2010)
Kinetic Dissection of the Pre-existing Conformational Equilibrium in the Trypsin Fold*
Austin D. Vogt (2015)
Molecular Mechanisms of Enzyme Activation by Monovalent Cations*
D. Gohara (2016)
The 2.8 A crystal structure of Gla‐domainless activated protein C.
T. Mather (1996)
A True Autoactivating Enzyme
P. Gál (2005)
Activation of proPHBSP, the Zymogen of a Plasma Hyaluronan Binding Serine Protease, by an Intermolecular Autocatalytic Mechanism
M. Etscheid (2000)
Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.
S. Igawa (2017)
Crystal structure of plasma kallikrein reveals the unusual flexibility of the S1 pocket triggered by Glu217
Mingming Xu (2018)
Cockroach protease allergen induces allergic airway inflammation via epithelial cell activation
S. Kale (2017)
Human Kallikrein 1,Tissue Kallikrein
J. Chao (2013)
Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors
Trine Tamberg (2018)
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Joakim E. Swedberg (2010)
Unleashing the therapeutic potential of human kallikrein-related serine proteases
I. Prassas (2015)
Mast cell proteases as pharmacological targets.
G. Caughey (2016)
Cysteine proteases of positive strand RNA viruses and chymotrypsin‐like serine proteases
A. Gorbalenya (1989)
Click Chemistry as a Tool for Cell Engineering and Drug Delivery
Yukiya Takayama (2019)
Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution.
M. Fujinaga (1987)
Definition and Redesign of the Extended Substrate Specificity of Granzyme B*
J. Harris (1998)
Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold*
J. Perona (1997)
Membrane-anchored serine proteases in vertebrate cell and developmental biology.
R. Szabo (2011)
MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked
J. Dobó (2016)
The interaction of thrombin with blood platelets
R. Lundblad (2005)
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator.
G. Spraggon (1995)
Age-Related Macular Degeneration: Insights into Inflammatory Genes
R. Cascella (2014)
Identification and functional characterization of a novel F5 mutation (Ala512Val, FVBonn) associated with activated protein C resistance
B. Pezeshkpoor (2016)
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
P. Goettig (2010)
Structure of complement component C2A: implications for convertase formation and substrate binding.
F. Milder (2006)
Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
E. Stura (2011)
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
J. Rotonda (2001)
Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates 1
Stefanos A. Tsiftsoglou (2004)
Der p 1 is the primary activator of Der p 3, Der p 6 and Der p 9 the proteolytic allergens produced by the house dust mite Dermatophagoides pteronyssinus.
J. Herman (2014)
MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity1
J. Dobó (2009)
Crystal structure of the proenzyme domain of plasminogen.
E. Peisach (1999)
Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity
Shihui Guo (2014)
Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19
K. Bateman (2001)
Lysine 156 promotes the anomalous proenzyme activity of tPA: X‐ray crystal structure of single‐chain human tPA
M. Renatus (1997)
Serine peptidases: Classification, structure and function
M. Page (2008)
The interaction of thrombin with fibrinogen. A structural basis for its specificity.
M. Stubbs (1992)
The anticoagulant protein C pathway
B. Dahlbäck (2005)
Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis
O. Susanto (2013)
Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa.
Thomas Zögg (2009)
Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target.
Md. Shenuarin Bhuiyan (2009)
Chapter 592 – γ-Tryptase
N. Trivedi (2013)
Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase*
S. Ke (1997)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood (2018)
Chapter 590 – Chymases
G. Caughey (2013)
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivation
T. J. Cramer (2011)
Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation
R. Friedrich (2003)
Structure of plasma and tissue kallikreins.
M. Pathak (2013)
Complement Factor I
Robert B Sim (2013)
Proteome-wide Identification of HtrA2/Omi Substrates.
L. Vande Walle (2007)
Substrate Specificity of Human Kallikrein 6
P. Angelo (2006)
High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor
S. P. Bajaj (2006)
Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers
J. Dorn (2014)
Asparagine‐linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity
Melinda Bence (2011)
Rigidification of the autolysis loop enhances Na(+) binding to thrombin.
N. Pozzi (2011)
Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation
T. Kromann-Hansen (2018)
Major Role of Human KLK14 in Seminal Clot Liquefaction*
Nashmil Emami (2008)
Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2*
A. Szabó (2016)
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
M. Debela (2008)
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
T. Kromann-Hansen (2017)
Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein Substrates
A. Jacquet (2017)
The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
V. Harmat (2004)
The Na+ Binding Site of Thrombin (*)
E. Di Cera (1995)
A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention
Nehemiah T. Zewde (2018)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
N. Rawlings (2018)
Kallikreins - The melting pot of activity and function.
Magdalena Kalińska (2016)
Proteolytic Activation of the Protease-activated Receptor (PAR)-2 by the Glycosylphosphatidylinositol-anchored Serine Protease Testisin*
K. H. Driesbaugh (2014)
Substrate specificities of the granzyme tryptases A and K.
K. Plasman (2014)
Novel mechanisms of Collagenase Santyl Ointment (CSO) in wound macrophage polarization and resolution of wound inflammation
Amitava Das (2018)
Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial Dysfunction.
H. Singh (2015)
Human β-tryptase is a ring-like tetramer with active sites facing a central pore
P. Pereira (1998)
Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution.
N. Trivedi (2008)
Plasmin substrate binding site cooperativity guides the design of potent peptide aldehyde inhibitors.
J. Swedberg (2011)
Distribution of 15 human kallikreins in tissues and biological fluids.
J. Shaw (2007)
The internal thioester and the covalent binding properties of the complement proteins C3 and C4
S. Law (1997)
Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
F. Forneris (2010)
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
S. Mortensen (2017)
Homologies in serine proteinases.
B. Hartley (1970)
Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis.
C. N. Fuhrmann (2006)
Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C.
W. Bode (1997)
Exfoliative Toxins – Staphylococcal Epidermolysins
G. Prévost (2013)
The 2.0-Å crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems
N. Kairies (2001)
Evolutionary families of peptidases.
N. Rawlings (1993)
Structural Insights into the Substrate Specificity of Human Granzyme H: The Functional Roles of a Novel RKR Motif
L. Wang (2012)
Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases*
Hyesook Yoon (2007)
Prekallikrein and Plasma Kallikrein
A. Schmaier (2013)
KLKs and their hormone-like signaling actions: a new life for the PSA-KLK family
M. Hollenberg (2014)
MMP20 and KLK4 activation and inactivation interactions in vitro.
Y. Yamakoshi (2013)
Interdependence of kallikrein-related peptidases in proteolytic networks
Nathalie Beaufort (2010)
Thrombin-like Enzymes from Snake Venoms: An Updated Inventory On behalf of the Scientific and Standardization Committee’s Registry of Exogenous Hemostatic Factors
H. Pirkle (1998)
Chapter 643 – Thrombin
B. L. Bonniec (2013)
Identification of CFTR, PRSS1, and SPINK1 Mutations in 381 Patients With Pancreatitis
Steven Keiles (2006)
Proteoforms of the platelet-aggregating enzyme PA-BJ, a serine proteinase from Bothrops jararaca venom.
E. T. Yamashiro (2014)
Inhibitors of kallikrein‐related peptidases: An overview
N. Masurier (2018)
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y
R. Szmola (2007)
1.2A-resolution crystal structures reveal the second tetrahedral intermediates of streptogrisin B (SGPB).
Ting-Wai Lee (2008)
Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7
M. Debela (2007)
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
V. Krishnan (2009)
Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors.
Chao-yie Yang (2016)
Human granzymes: related but far apart.
F. Vahedi (2014)
Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.
B. Doak (2014)
Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151.
C. Gaboriaud (1996)
Structure of crystalline -chymotrypsin. V. The atomic structure of tosyl- -chymotrypsin at 2 A resolution.
J. Birktoft (1972)
Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
M. Debela (2006)
Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
R. Ménez (2008)
The kallikrein-kinin system as a regulator of cardiovascular and renal function.
N. Rhaleb (2011)
Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms
Hyesook Yoon (2018)
Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.
A. Rezaie (2000)
Neuropsin—A possible modulator of synaptic plasticity
S. Shiosaka (2011)
Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
P. Martin (1996)
Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics
B. T. Riley (2016)
Unraveling the allosteric mechanism of serine protease inhibition by an antibody.
Rajkumar Ganesan (2009)
The Origin of Trypsin: Evidence for Multiple Gene Duplications in Trypsins
A. M. Baptista (1998)
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
V. Gratio (2011)
Residues of the 39-Loop Restrict the Plasma Inhibitor Specificity of Factor IXa*
L. Yang (2013)
Chapter 602 – Acrosin
I. Adham (2013)
Interaction of Calcium with Native and Decarboxylated Human Factor X.
A. Sabharwal (1997)
C1q: A fresh look upon an old molecule.
N. Thielens (2017)
Molecular Dissection of Na+ Binding to Thrombin*
A. Pineda (2004)
Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of alzheimer's amyloid β‐protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): Engineering of inhibitors with altered specificities
A. Scheidig (1997)
Proteases as therapeutics.
C. Craik (2011)
Structural determinants of specificity and regulation of activity in the allosteric loop network of human KLK8/neuropsin
M. Debela (2018)
A proteolytic cascade of kallikreins in the stratum corneum.
M. Brattsand (2005)
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response
M. Panos (2014)
Structural and Mutational Analyses of the Molecular Interactions between the Catalytic Domain of Factor XIa and the Kunitz Protease Inhibitor Domain of Protease Nexin 2*
D. Navaneetham (2005)
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15
Hyesook Yoon (2009)
A unique group of inactive serine protease homologues from snake venom.
J. Wu (2008)
450 million years of hemostasis
C. J. Davidson (2003)
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
D. Thorek (2018)
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
T. Liu (2005)
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.
R. Huber (1974)
Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin
W. Li (2004)
A family of serine esterases in lytic granules of cytolytic T lymphocytes
D. Masson (1987)
Neutrophil‐derived azurocidin alarms the immune system
O. Soehnlein (2009)
Enzyme specificity under dynamic control II: Principal component analysis of α‐lytic protease using global and local solvent boundary conditions
N. Ota (2001)
Structure of an engineered, metal-actuated switch in trypsin.
M. Mcgrath (1993)
Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA.
A. Carvalho (2002)
The DegP and DegQ periplasmic endoproteases of Escherichia coli: specificity for cleavage sites and substrate conformation.
H. Kolmar (1996)
Serine Endopeptidase Allergens from Dermatophagoides Species
T. Takai (2013)
Perforin and granzymes: function, dysfunction and human pathology
I. Voskoboinik (2015)
Three dimensional structures of S189D chymotrypsin and D189S trypsin mutants: the effect of polarity at site 189 on a protease-specific stabilization of the substrate-binding site.
E. Szabó (2003)
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
H. Brandstetter (1995)
Structural insights into the activation mechanisms of human HtrA serine proteases.
D. Żurawa-Janicka (2017)
Reincarnation of ancient links between coagulation and complement
E. Conway (2015)
Structural and functional analysis of HtrA1 and its subdomains.
C. Eigenbrot (2012)
Prostasin Is a Glycosylphosphatidylinositol-anchored Active Serine Protease*
L. Chen (2001)
Refined X-ray crystallographic structure of the poliovirus 3C gene product.
S. Mosimann (1997)
HtrA protease family as therapeutic targets.
J. Skorko-Glonek (2013)
Activity-controlled proteolytic cleavage at the synapse
P. Sonderegger (2014)
Substrate-induced remodeling of the active site regulates human HTRA1 activity
Linda Truebestein (2011)
Processing of Neuregulin-1 by Neuropsin Regulates GABAergic Neuron to Control Neural Plasticity of the Mouse Hippocampus
Hideki Tamura (2012)
Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma
C. Watters (2016)
Biochemical and biological aspects of the plasminogen activation system.
M. Mayer (1990)
Creating functional sophistication from simple protein building blocks, exemplified by factor H and the regulators of complement activation.
Elisavet Makou (2015)
A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity*
Shihui 世辉) Guo (郭 (2015)
The long road of research on snake venom serine proteinases.
S. Serrano (2013)
Chymotrypsin C (Caldecrin) Stimulates Autoactivation of Human Cationic Trypsinogen*
Z. Nemoda (2006)
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
C. Deraison (2007)
Interaction of Mite Allergens Der P3 and Der P9 with Protease-Activated Receptor-2 Expressed by Lung Epithelial Cells1
G. Sun (2001)
Diverse stability and catalytic properties of human tryptase α and β isoforms are mediated by residue differences at the S1 pocket
T. Selwood (2002)
Human α-, β- and δ-Tryptases
N. Trivedi (2013)
The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities.
P. Hof (1996)
Enteropeptidase, a type II transmembrane serine protease.
X. Zheng (2009)
Crystal Structure of Neuropsin, a Hippocampal Protease Involved in Kindling Epileptogenesis*
Tadaaki Kishi (1999)
Hemophilia A and B: molecular and clinical similarities and differences
G. Castaman (2019)
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Xiaocong Geng (2018)
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions
M. Huber-Lang (2017)
Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
K. Vadivel (2019)
Catalytic Mechanisms of Serine and Threonine Peptidases
L. Polgár (2013)
Three-dimensional Structure of Tosyl-α-chymotrypsin
B. Matthews (1967)
Hepsin and prostate cancer.
Q. Wu (2007)
Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase‐activated receptor‐2
D. Polley (2017)
Mesotrypsin, a brain trypsin, activates selectively proteinase‐activated receptor‐1, but not proteinase‐activated receptor‐2, in rat astrocytes
Y. Wang (2006)
New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System
C. Ehrnthaller (2011)
Coevolution of the coagulation and immune systems
B. Arneth (2018)
In vivo roles of factor XII.
T. Renné (2012)
Type II Transmembrane Serine Proteases*
Thomas H. Bugge (2009)
Induced Fit Is a Special Case of Conformational Selection.
P. Chakraborty (2017)
NSP4, an elastase-related protease in human neutrophils with arginine specificity
N. C. Perera (2012)
Haemophilias A and B
P. Bolton-Maggs (2003)
Structural studies of plasmin inhibition.
Guojie Wu (2019)
Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation.
Thomas Zögg (2011)
The role of type II transmembrane serine protease‐mediated signaling in cancer
Lauren M Tanabe (2017)
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
Katherine E. Lintner (2016)
The Role of Dust Mites in Allergy
J. Miller (2018)
HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening
K. Dynon (2012)
Contribution of the 60 Loop To Substrate and Inhibitor Specificity of Thrombin.
A. Rezaie (2004)
Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity*
W. Skala (2014)
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells
J. Hu (2015)
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
K. Sichler (2002)
Structural basis of the zinc inhibition of human tissue kallikrein 5.
M. Debela (2007)
Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays.
S. H. Qureshi (2008)
Complement genetics, deficiencies, and disease associations
K. R. Mayilyan (2012)
Human urinary kallikrein--amino acid sequence and carbohydrate attachment sites.
J. Kellermann (1988)
How Na+ activates thrombin – a review of the functional and structural data
J. Huntington (2008)
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies
M. Avgeris (2016)
Specificity profiling of human trypsin-isoenzymes
O. Schilling (2018)
Proteases of the complement system.
Robert B Sim (2004)
Tissue plasminogen activator in central nervous system physiology and pathology.
Jerry P. Melchor (2005)
Evolution of enzyme cascades from embryonic development to blood coagulation.
M. Krem (2002)
Structure of the C1r–C1s interaction of the C1 complex of complement activation
Jamal O M Almitairi (2018)
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.
Nisha R. Pawar (2019)
Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.
X. Wang (1998)
Structure and Function of the Haemophilus influenzae Autotransporters
Nicole A. Spahich (2011)
Complement factor I in health and disease.
Sara C. Nilsson (2011)
The Critical Role of the 185–189-Loop in the Factor Xa Interaction with Na+ and Factor Va in the Prothrombinase Complex*
A. Rezaie (2004)
Structures of human proteinase 3 and neutrophil elastase – so similar yet so different
Eric Hajjar (2010)
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
D. Loessner (2018)
Activation and activity of glycosylated KLKs 3, 4 and 11
Shihui Guo (2018)
Glutamyl Endopeptidases: The Puzzle of Substrate Specificity
I. Demidyuk (2017)
Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
Sabine Reyda (2003)
Structural basis for complement factor I control and its disease-associated sequence polymorphisms
P. Roversi (2011)
Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
K. Ponnuraj (2004)
1.70 Å X‐ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding
Gurunathan Laxmikanthan (2005)
Functional Roles of Human Kallikrein-related Peptidases*
G. Sotiropoulou (2009)
Na+ binding to meizothrombin desF1
M. Papaconstantinou (2008)
Convergent Evolution of Novel Protein Function in Shrew and Lizard Venom
Yael T. Aminetzach (2009)
Structures of neutrophil serine protease 4 reveal an unusual mechanism of substrate recognition by a trypsin-fold protease.
S. Lin (2014)
Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
N. Ahmed (2016)
Corin Mutations K317E and S472G from Preeclamptic Patients Alert Zymogen Activation and Cell Surface Targeting*
N. Dong (2014)
HtrA proteins as targets in therapy of cancer and other diseases
D. Żurawa-Janicka (2010)
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
D. Lamba (1996)
Chapter 571 – HtrA1 Peptidase
J. Chien (2013)
Identification of tubulins as substrates of serine protease HtrA1 by mixture‐based oriented peptide library screening
J. Chien (2009)
Physiological fIXa Activation Involves a Cooperative Conformational Rearrangement of the 99-Loop*
K. Sichler (2003)
A Review and Database of Snake Venom Proteomes
Theo Tasoulis (2017)
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
M. Etscheid (2012)
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities
A. Schmaier (2016)
Autoproteolysis or Plasmin-mediated Cleavage of Factor Xaα Exposes a Plasminogen Binding Site and Inhibits Coagulation*
E. L. Pryzdial (1996)
Important Role of the Cys-191–Cys-220 Disulfide Bond in Thrombin Function and Allostery*
Leslie A. Bush-Pelc (2007)
Chapter 569 – DegP Protease
Niklas Weber (2013)
This paper is referenced by
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H. Shrimp (2020)
FAM111A regulates replication origin activation and cell fitness
Diana O. Rios-Szwed (2020)
Exosites expedite blood coagulation
M. L. Oliva (2020)
Platelet Membrane Receptor Proteolysis: Implications for Platelet Function
Jiayu Wu (2020)
N-glycan in the scavenger receptor cysteine-rich domain of hepsin promotes intracellular trafficking and cell surface expression.
Shijin Sun (2020)
Characterization of the trypsin-III from Monterey sardine (Sardinops caeruleus): Insights on the cold-adaptation from the A236N mutant.
Manuel I Carretas-Valdez (2020)
Impact of protein dynamics on secondary structure prediction.
A. G. Brevern (2020)
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H. Shrimp (2020)
FAM111A regulates replication origin activation and cell fitness
Diana O. Rios-Szwed (2020)